In Vitro and In Vivo Pharmacology

In Vitro and In Vivo Pharmacology

ADME

In Vitro Screening and In Vivo Pharmacology

UPP has established wide range of in vitro screening platforms which can support biochemical and cell-based assays for target identification, validation and compound developability assessments. In addition, UPP has vast experience in the areas of preclinical PK/PD studies in rodent and non-rodent species including routine in vivo pharmacokinetic studies, animal models in different therapeutic areas and non-GLP toxicity assessments. UPP Guangxi facility has been accredited for PK/PD studies using radiolabeled material in support of various stages of drug discovery and development.

• In Vitro Screening Platforms

• In Vivo PK and PK/PD Studies
  UPP has been working closely with more than 400 sponsors for projects at different stages of drug discovery and development. We gained extensive experience in support of preclinical and clinical PK and PK/PD studies for biomolecules, small molecules and new therapeutic modalities.
   

• In Vivo Pharmacology and Animal Model